Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence

Hjartarson HT, Nathorst-Böös K, Sejersen T

Drug Design, Development and Therapy 2022, 16:1865-1883

Published Date: 16 June 2022